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ABSTRACT 
Formulation development is an important part of drug design and development. Bioavailability and bioequivalence are totally dependent on 
formulation development. Now-a-days formulation development is done by following QbD (Quality by Design).The aim of present study is to 
formulate Gemfibrozil (Gem) sustained release (SR) and immediate release (IR) bilayer tablet by different concentration of Hydroxypropyl 
methylcellulose (HPMC) and HPMC K 100 M to control the release pattern. The sustained release layer of Gem was prepared by using different 
grades of HPMC like, HPMC K-15, HPMC K-4 along with other excipients by direct compression technique. The immediate release layer of Gem 
was prepared by Cross carmellose sodium, Crospovidone and Sodium starch glycolate by direct compression technique. The powders were 
evaluated for their flow properties and the finished tablets were evaluated for their physical parameters. The both immediate release and 
sustained release layers of Gem were characterized by FT-IR and in vitro dissolution studies. The drug release study of Gem was evaluated 
using USP-II paddle type dissolution apparatus. The release rate of Gem in immediate release layer was studied for 15 min in 0.1 N HCL media 
and that of Gem in sustained release layer was studied for 12 h in 0.1 N HCL. From the nine batches F6 batch showed good release behaviour 
99.85% of drug is released over 12 hours. Gem belongs to BCS Class II (log P 3.6) with poor solubility and high permeability resulting in limited 
and variable bioavailability. Total four trial batches of each drug have been manufactured to optimize and develop a robust and stable 
formulation, the stability studies of the products also comply with ICH guideline. 
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INTRODUCTION 
The bilayer tablet is a concept which is composed of 
different layers. The system allows the incorporation of 
more than one drug into the dosage form. Formulation of 
layers from different polymers allows manipulation over 
more than one rate-controlling polymer, thus enabling 
different types of drug delivery of one or more drugs1. 
Floating Bilayer drug delivery system is combined principle 
of bilayer tablet as well as floating mechanism. Floating 
Bilayer tablet is suitable for sequential release of two drugs 
in combination, separate two incompatible substances and 
also for sustained release tablet in which one layer is 
immediate release as initial dose and second layer is 
maintenance dose2. Floating drug delivery systems have a 
bulk density less than gastric fluids and so remain buoyant 
in the stomach without affecting the gastric emptying rate 
for a prolonged period of time3. While the system is floating 
on the gastric contents, the drug is released slowly at the 
desired rate from the system. Bioavailability of poorly 
water‐soluble hydrophobic drugs is limited by their 
solubility and dissolution rate4,5. Gemfibrozil (Gem) is a 
widely used antihyperlipidemic agent classified as fibric acid 
derivative. It increases the activity of extrahepatic 
lipoprotein lipase, resulting in the lipolysis process6. Gem 
activates peroxisome proliferator-activated receptor-alpha 
transcriptor factor ligand, a receptor that is involved in the 
metabolism of carbohydrates and fats and also in adipose 
tissue distribution7. This results in increased synthesis of 
lipoprotein lipase thereby increasing the clearance of 
triglyceride. Gem belongs to BCS Class II (log P 3.6) with 
poor solubility and high permeability resulting in limited 
and variable bioavailability8,9. In the present study, a bilayer 
tablet for bimodal drug release in which one layer of 
immediate release and second layer of sustained release of 
Gem was designed by direct compression method. 
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MATERIALS AND METHODS 
Gem was obtained from Aurobindo Pharma, Hyderabad, as a 
gift sample. HPMC K4, K15, PVP K30 was obtained from 
Mapromax, Life sciences Pvt. Ltd. Dehradun. Sodium 
bicarbonate, citric acid, magnesium stearate and talc were 
obtained from Loba Chemical Pvt Ltd (Mumbai, India). 
Hydrochloric acid was obtained from S. D. Fine Chem. Ltd., 
Mumbai. All other chemical were purchased from Hi Media, 
Mumbai. Double distilled water was prepared freshly and 
used whenever required. All other chemicals used in this 
study including those stated were of analytical reagent (A.R.) 
grade. 
Procedure for the determination of λ max 
Accurately weighed 10 mg of Gem separately and dissolved 
in 10 ml of 0.1N HCL in 10 ml of volumetric flask and 
prepared suitable dilution to make it to a concentration of 
100 μg/ml make adequate of sample with concentration 
range of 5-25μg/ml Gem calculate the spectrum of this 
solution was run in 200-400 nm range in U.V 
spectrophotometer (Labindia UV 3000 +). The higher 
absorption peak was obtained at 278nm which was the 
λmax of drug. 
Formulation development  
Formulation of immediate release (IR) layer 
The immediate release granules were prepared by blending 
the drug with different concentration of superdisintegrants 
like sodium starch glycolate, crospovidone, croscarmellose 
sodium and other excipients like microcrystalline cellulose 
by direct compression method. The powder blend was 
lubricated with magnesium stearate and talc. A weighed 
quantity of above lubricated drug mixture blend was fed 
manually into the die and directly compressed using 8 mm 
flat faced punch of 16 station Rimek mini press rotary 
compression machine to get IR layer. Nine formulation 
batches with different super superdisintegrants were made 
in order to achieve desired disintegration time and drug 
release. The composition of Gem immediate release tablets 
were shown in Table 1. 
Formulation of floating sustained release (SR) layer 
The floating sustained release granules were prepared by 
direct compression technique. Required quantity of Gem and 
polymers like HPMC K4, HPMC K15, PVP K30, alkalizing 
agent sodium bicarbonate and acidifying agent citric acid 
were weighed and passed through sieve with mesh #40 and 
were mixed homogeneously in a poly-bag for about 5-10 min 
and was taken in a mort. The powder mass was passed 
through mesh #14. Finally the powder was lubricated with 
lactose and talc Table 2. 
Formulation of bilayer tablet 
Optimized formulation IF-6 of immediate release layer and 
optimized formulation of F-6 for sustained release used for 
formulation of Bi-layer tablet. 
 
Table 1 Composition of Gemfibrozil fast dissolving tablets 
Ingredients(mg) 
Formulation code 
IF1 IF 2 IF 3 IF 4 IF 5 IF 6 IF 7 IF 8 IF 9 
Gemfibrozil  200 200 200 200 200 200 200 200 200 
Sodium Starch glycolate 15 20 25 - - - - - - 
Croscarmellose sodium 
 
- - 15 20 25 - - - 
Crospovidone 
 
- - - - - 15 20 25 
Microcrystalline cellulose 24 19 14 24 19 14 24 19 14 
Talc 5 5 5 5 5 5 5 5 5 
Magnesium stearate 6 6 6 6 6 6 6 6 6 
Total weight 250 250 250 250 250 250 250 250 250 
 
Table 2 Formulation of sustained release floating layer 
Excipients(mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 
Gemfibrozil 400 400 400 400 400 400 400 400 400 
HPMC K 15 - - - - --  100 120 140 50 60 70 
HPMC K 4 100 120 140 --  --  --  50 60 70 
PVP K30 10 10 10 10 10 10 10 10 10 
Citric acid 5 5 5 5 5 5 5 5 5 
NaHCO3 15 15 15 15 15 15 15 15 15 
Mg(C18H35O2)2 5 5 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 5 5 
Lactose 60 40 20 60 40 20 60 40 20 
Total Weight 600 600 600 600 600 600 600 600 600 
 
Evaluation of precompression parameter  
Angle of repose (θ) 
The angle of repose was determined by using fixed funnel 
method. The physical mixtures of drug with different 
excipients were prepared and the accurately weighed drug 
powder or its physical mixture was taken in a funnel. The 
height of the funnel was adjusted in such a way that the tip 
of the funnel just touches the apex of the heap of the drug 
powder. The powder was allowed to flow through the funnel 
freely onto surface. The angle of repose was calculated using 
the following equation. 
θ = tan-1(h/r) 
Where, h and r are the height and radius of the powder cone 
respectively. 
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Bulk density 
Both loose bulk density (LBD) and tapped density (TBD) 
were determined were calculated using the following 
formulas. 
LBD = Powder weight/volume of the packing 
TBD = Powder weight /tapped volume of the packing 
Compressibility index 
 The compressibility index of the granules was determined 
by Carr’s compressibility index. 
Carr’s index (%) = [(TBD – LBD)/TBD] × 100. 
Hausner’s ratio 
Hausner’s ratio is an indirect index of ease of measuring the 
powder flow. It was calculated by the following formula10-12. 
Hausner’s ratio = Tapped density/Bulk density. 
Evaluation of post compression Parameter  
General appearance 
Morphological characters like shape and texture was 
determined visually. 
Thickness 
Thickness and diameter of tablets were determined using 
Vernier caliper. Five tablets from each batch were used and 
an average value was calculated. 
Hardness 
For each formulation, the hardness of five tablets was 
determined using the Monsanto hardness tester (Cadmach) 
and measured in terms of kg/cm2. 
Weight variation 
The weight variation test was performed as per the U.S 
guidelines. Twenty randomly taken tablets were weighed 
together and the average weight was determined. Each 
tablet was then weighed individually and deviation from 
average weight was calculated. 
Friability 
A sample of twenty randomly selected tablets were 
accurately weighed and placed in a Roche friabilator. The 
friabilator was operated for 4 min at a speed of 25 rpm. The 
tablets were removed from the friabilator, de-dusted and 
reweighed. The percent loss in weight due to abrasion and 
impact was calculated as, 
%Friability= (Loss in weight/ Initial weight) x 100 
Drug content 
Twenty tablets were taken and amount of drug present in 
each tablet was determined. The tablets were crushed in a 
mortar and the powder equivalent to 100mg of drug was 
transferred to 100ml standard flask. The powder was 
dissolved in 50 ml of 0.1 N HCL and made up to volume with 
of 0.1 N HCl. The sample was mixed thoroughly and filtered 
through a 0.45μ membrane filter. The filtered solution was 
diluted suitably and reacts with dye and analyzed for drug 
content by UV spectrophotometer at a λ max of 278.0nm 
using of 0.1 N HCL as blank. 
Buoyancy lag time determination & total floating time 
In vitro buoyancy was determined by floating lag time as per 
the method described below. The tablets were placed 
separately in a 100 ml glass beaker containing simulated 
gastric fluid (SGF), pH 1.2 as per USP. The time required for 
the tablet to rise to the surface for floating was determined 
as the buoyancy lag time and further total floating time of all 
tablets was determined by visual observation. 
In vitro disintegration time of immediate release tablets 
The disintegration time for all immediate release 
formulations was carried out using tablet disintegration test 
apparatus. Six tablets were placed individually in each tube 
of disintegration test apparatus and discs were placed. The 
medium, water was maintained at a temperature of 37° ± 
2°C and time taken for the entire tablet to disintegrate 
completely was noted. 
In vitro dissolution studies 
In vitro drug release of the sample was carried out using 
USP- type II dissolution apparatus (Paddle type). The 
dissolution medium, 900 ml 0.1N HCl was placed into the 
dissolution flask maintaining the temperature of 37±0.50C 
and rpm of 75. One Betahistine tablet was placed in each 
basket of dissolution apparatus. The apparatus was allowed 
to run for 10 hours. Sample measuring 5 ml were withdrawn 
after every 1 hour up to 10 hours using 10ml pipette. The 
fresh dissolution medium (370C) was replaced every time 
with the same quantity of the sample. From this take 0.5 ml 
and dilute up to 10 ml with 0.1 N HCL and take the 
absorbance at 278nm using spectroscopy. 
Stability studies 
The stability of Gem bilayer floating tablets to assess their 
stability with respect to their physical appearance, drug 
content and release characteristics after storing at 
25°C/60% RH and 40°C/75% RH in properly closed HDPE 
bottles along with 1 g desiccant for 3 months. 
RESULTS AND DISCUSSIONS 
Solubility of Gem was soluble in ethanol, methanol, 
chloroform, 0.1N HCl water, sparingly soluble in water, 0.1 N 
NaOH, 6.8 pH Phosphate buffer. The melting point of Gem 
was 58-61°C and λ max of Gem was found to be 278 nm by 
using U.V. spectrophotometer (Labindia-3000+) in linearity 
range 5-25 µg/ml Fig.1. 
 
Fig. 1Calibration curve of gemfibrozil in 0.1 HCL at 278 
nm 
The powdered blends of different formulations of immediate 
release tablets and sustained release floating tablets were 
evaluated for angle of repose, bulk density (BD), tapped 
density (TBD) and compressibility index. The results of 
immediate release tablets and SR floating tablets are 
summarized in Table 3& 4. The results of SR floating tablets 
of BD and TBD ranged from 0.478to 0.489and 0.571to 
0.589respectively. The range of Hausner ratio and 
compressibility index was found to be 1.168 to 1.230 and 
14.361to 18.676respectively. The results of angle of repose 
(<25) indicate good flow properties of the powdered blend. 
The formulation of immediate release tablet prepared by 
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using the superdisintegrants exhibited the LBD, TBD, angle 
of repose, compressibility index and Hausner’s ratio of 
within the range, which shows good flow properties of the 
powdered blend. 
 
Table 3 Results of pre-compression parameters of powder blend of immediate release 
Formulation 
code 
Parameters 
Loose Bulk 
density(gm/ml) 
Tapped bulk 
density(gm/ml) 
Carr’s 
Index (%) 
Hausner’s 
Ratio 
IF1 0.456 0.535 14.766 1.173 
IF2 0.469 0.536 12.500 1.143 
IF3 0.476 0.537 11.359 1.128 
IF4 0.471 0.532 11.466 1.130 
IF5 0.475 0.541 12.200 1.139 
IF6 0.479 0.539 11.132 1.125 
IF7 0.475 0.541 12.200 1.139 
IF8 0.472 0.532 11.278 1.127 
IF9 0.476 0.541 12.015 1.137 
 
Table 4 Result of pre-compression properties of sustained release floating tablets 
Material Bulk 
density(gm/ml) 
Tapped 
density(gm/ml) 
Compressibility 
index 
Hausner’s 
ratio 
F1 0.489 0.578 15.398 1.182 
F2 0.485 0.582 16.667 1.200 
F3 0.482 0.579 16.753 1.201 
F4 0.479 0.589 18.676 1.230 
F5 0.485 0.578 16.090 1.192 
F6 0.489 0.571 14.361 1.168 
F7 0.482 0.573 15.881 1.189 
F8 0.485 0.574 15.505 1.184 
F9 0.478 0.582 17.869 1.218 
 
The prepared tablets were evaluated for different physico-
chemical properties and the results are summarized in Table 
5 & 6. The tablets were white, circular in shape and were 
found to be uniform with respect to weight variation, 
hardness; thickness, friability and content uniformity of 
different batch of tablets were found within acceptable 
range and the distribution of drug in all the formulations 
was uniform. 
 
Table 5 Results of post-compression parameters of immediate release 
F. Code Hardness 
test (kg/cm2) 
Friability 
(%) 
Weight 
variation (%) 
Thickness 
(mm) 
Drug 
content (%) 
 
In vitro Disintegration Time 
(sec.) (n=3) Mean ± SD 
IF1 3.2 0.856 255 2.45 95.56 115±8 
IF2 3.4 0.789 250 2.42 97.89 98±9 
IF3 3.3 0.658 256 2.39 98.85 88±8 
IF4 3.4 0.456 260 2.45 98.78 125±9 
IF5 3.4 0.521 245 2.48 98.85 110±6 
IF6 3.5 0.478 248 2.43 99.25 105±8 
IF7 3.4 0.652 252 2.42 98.78 165±9 
IF8 3.4 0.745 255 2.41 97.78 133±9 
IF9 3.4 0.658 255 2.43 98.85 120±5 
 
Table 6 Results of post compression properties of sustained release floating tablets 
F. Code Thickness 
(mm) 
Hardness 
(kg/cm2) 
Weight variation 
(mg) 
Friability 
(%) 
Drug 
content (%) 
Floating lag 
times (sec) 
Total Floating 
Time (hrs) 
F1 3.45 5.2 605 0.658 98.78 56 >12 
F2 3.52 5.3 610 0.554 98.12 58 >12 
F3 3.49 5.4 595 0.587 99.12 62 >12 
F4 3.41 5.2 588 0.478 97.85 78 >12 
F5 3.51 5.2 596 0.489 98.65 85 >12 
F6 3.48 5.3 605 0.458 99.25 92 >12 
F7 3.47 5.4 610 0.569 99.32 85 >12 
F8 3.49 5.2 605 0.854 99.56 94 >12 
F9 3.47 5.1 595 0.658 98.98 81 >12 
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The prepared bilayer tablets were evaluated for different 
physico-chemical properties and the results are summarized 
in Table 7. The tablets were found to be uniform with 
respect to weight variation and hardness (6.20±0.2kg/cm2). 
The thickness (5.42±0.03mm) and friability (0.658±0.062%) 
of optimized batch of tablets were found within acceptable 
range. Content uniformity of formulations was found to be 
98.96%, where the distribution of drug in all the 
formulations was uniform. 
 
Table 7 Post-compressional parameters of bilayer tablets 
Formulation Hardness 
test (kg/cm2) 
Friability 
(%) 
Weight 
variation 
Thickness 
(mm) 
Gemfibrozil 
(% Label Claim) 
1. 6.20±0.2 0.658±0.062 Passes 5.42±0.03 98.96 
 
The Instant layer of Gem release Approx 98.00±1.23 percent 
drug within 15 minutes and control floating layer Gem 
shows release up to 12 Hours Approx 99.89 percent. The 
release of bilayer tablet is shown in Fig.2.  
 
Fig. 2 Graph of release of bilayer tablets 
CONCLUSION  
Based on the above study, it can be concluded that 
Gemfibrozil, a conventional drug for antihyperlipidemic 
activity can be successfully formulated in the form of bilayer 
tablet by optimizing drug polymer ratio using different 
grades of common polymers like HPMC K4, HPMC K 15 etc. 
This is basically done to improve bioavailability of the drug 
and better therapeutic compliance. The sustained layer of 
the drug showed steady state release behaviour over a 
prolonged duration of time which may reduce dose related 
side effects. In future, natural biodegradable polymers can 
be used to improve therapeutic efficacy of the drug and 
further minimizing side effects. 
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